A subretinal implant termed CPCB-RPE1 is currently being developed to surgically replace dystrophic RPE in patients with dry age-related macular degeneration (AMD) and severe vision loss. CPCB-RPE1 is composed of a terminally differentiated, polarized human embryonic stem cell-derived RPE (hESC-RPE) monolayer pre-grown on a biocompatible, mesh-supported submicron parylene C membrane. The objective of the present delivery study was to assess the feasibility and 1-month safety of CPCB-RPE1 implantation in Yucatán minipigs, whose eyes are similar to human eyes in size and gross retinal anatomy.
This was a prospective, partially blinded, randomized study in 14 normal-sighted female Yucatán minipigs (aged 2 months, weighing 24–35 kg). Surgeons were blinded to the randomization codes and postoperative and post-mortem assessments were performed in a blinded manner. Eleven minipigs received CPCB-RPE1 while three control minipigs underwent sham surgery that generated subretinal blebs. All animals except two sham controls received combined local (Ozurdex™ dexamethasone intravitreal implant) and systemic (tacrolimus) immunosuppression or local immunosuppression alone. Correct placement of the CPCB-RPE1 implant was assessed by in vivo optical coherence tomography and post-mortem histology. hESC-RPE cells were identified using immunohistochemistry staining for TRA-1-85 (a human marker) and RPE65 (an RPE marker). As the study results of primary interest were nonnumerical no statistical analysis or tests were conducted.
CPCB-RPE1 implants were reliably placed, without implant breakage, in the subretinal space of the minipig eye using surgical techniques similar to those that would be used in humans. Histologically, hESC-RPE cells were found to survive as an intact monolayer for 1 month based on immunohistochemistry staining for TRA-1-85 and RPE65.
Although inconclusive regarding the necessity or benefit of systemic or local immunosuppression, our study demonstrates the feasibility and safety of CPCB-RPE1 subretinal implantation in a comparable animal model and provides an encouraging starting point for human studies.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY (2012) Age-related macular degeneration. Lancet 379(9827):1728–1738. doi:10.1016/S0140-6736(12)60282-7
Peyman GA, Blinder KJ, Paris CL, Alturki W, Nelson NC Jr, Desai U (1991) A technique for retinal pigment epithelium transplantation for age-related macular degeneration secondary to extensive subfoveal scarring. Ophthalmic Surg 22(2):102–108
Algvere PV, Berglin L, Gouras P, Sheng Y, Kopp ED (1997) Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Graefes Arch Clin Exp Ophthalmol 235(3):149–158
Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK, Ostrick RM, Mickunas E, Gay R, Klimanskaya I, Lanza R (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713–720. doi:10.1016/S0140-6736(12)60028-2
Binder S, Stanzel BV, Krebs I, Glittenberg C (2007) Transplantation of the RPE in AMD. Prog Retin Eye Res 26(5):516–554. doi:10.1016/j.preteyeres.2007.02.002
da Cruz L, Chen FK, Ahmado A, Greenwood J, Coffey P (2007) RPE transplantation and its role in retinal disease. Prog Retin Eye Res 26(6):598–635. doi:10.1016/j.preteyeres.2007.07.001
Lu B, Zhu D, Hinton D, Humayun MS, Tai YC (2012) Mesh-supported submicron parylene-C membranes for culturing retinal pigment epithelial cells. Biomed Microdevices 14(4):659–667. doi:10.1007/s10544-012-9645-8
Hu Y, Liu L, Lu B, Zhu D, Ribeiro R, Diniz B, Thomas PB, Ahuja AK, Hinton DR, Tai YC, Hikita ST, Johnson LV, Clegg DO, Thomas BB, Humayun MS (2012) A novel approach for subretinal implantation of ultrathin substrates containing stem cell-derived retinal pigment epithelium monolayer. Ophthalmic Res 48(4):186–191. doi:10.1159/000338749
Rowland TJ, Blaschke AJ, Buchholz DE, Hikita ST, Johnson LV, Clegg DO (2013) Differentiation of human pluripotent stem cells to retinal pigmented epithelium in defined conditions using purified extracellular matrix proteins. J Tissue Eng Regen Med 7(8):642–653. doi:10.1002/term.1458
Pennington BO, Clegg DO, Melkoumian ZK, Hikita ST (2015) Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate. Stem Cells Transl Med 4(2):165–177. doi:10.5966/sctm.2014-0179
Hsiung J, Zhu D, Hinton DR (2015) Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures. Stem Cells Transl Med 4(1):10–20. doi:10.5966/sctm.2014-0205
Diniz B, Thomas P, Thomas B, Ribeiro R, Hu Y, Brant R, Ahuja A, Zhu D, Liu L, Koss M, Maia M, Chader G, Hinton DR, Humayun MS (2013) Subretinal implantation of retinal pigment epithelial cells derived from human embryonic stem cells: improved survival when implanted as a monolayer. Invest Ophthalmol Vis Sci 54(7):5087–5096. doi:10.1167/iovs.12-11239
Tang PH, Buhusi MC, Ma JX, Crouch RK (2011) RPE65 is present in human green/red cones and promotes photopigment regeneration in an in vitro cone cell model. J Neurosci 31(50):18618–18626. doi:10.1523/JNEUROSCI.4265-11.2011
Del Priore LV, Tezel TH, Kaplan HJ (2004) Survival of allogeneic porcine retinal pigment epithelial sheets after subretinal transplantation. Invest Ophthalmol Vis Sci 45(3):985–992
Guduric-Fuchs J, Chen W, Price H, Archer DB, Cogliati T (2011) RPE and neuronal differentiation of allotransplantated porcine ciliary epithelium-derived cells. Mol Vis 17:2580–2595
Kiilgaard JF, Prause JU, Prause M, Scherfig E, Nissen MH, la Cour M (2007) Subretinal posterior pole injury induces selective proliferation of RPE cells in the periphery in in vivo studies in pigs. Invest Ophthalmol Vis Sci 48(1):355–360. doi:10.1167/iovs.05-1565
Kiilgaard JF, Scherfig E, Prause JU, la Cour M (2012) Transplantation of amniotic membrane to the subretinal space in pigs. Stem Cells Int 2012:716968. doi:10.1155/2012/716968
Kyhn MV, Kiilgaard JF, Lopez AG, Scherfig E, Prause JU, la Cour M (2008) Functional implications of short-term retinal detachment in porcine eyes: study by multifocal electroretinography. Acta Ophthalmol 86(1):18–25. doi:10.1111/j.1600-0420.2007.00983.x
Li SY, Yin ZQ, Chen SJ, Chen LF, Liu Y (2009) Rescue from light-induced retinal degeneration by human fetal retinal transplantation in minipigs. Curr Eye Res 34(7):523–535
Maaijwee KJ, van Meurs JC, Kirchhof B, Mooij CM, Fischer JH, Mackiewicz J, Kobuch K, Joussen AM (2007) Histological evidence for revascularisation of an autologous retinal pigment epithelium--choroid graft in the pig. Br J Ophthalmol 91(4):546–550. doi:10.1136/bjo.2006.103259
Warfvinge K, Kiilgaard JF, Klassen H, Zamiri P, Scherfig E, Streilein W, Prause JU, Young MJ (2006) Retinal progenitor cell xenografts to the pig retina: immunological reactions. Cell Transplant 15(7):603–612
Binder S, Krebs I, Hilgers RD, Abri A, Stolba U, Assadoulina A, Kellner L, Stanzel BV, Jahn C, Feichtinger H (2004) Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: a prospective trial. Invest Ophthalmol Vis Sci 45(11):4151–4160. doi:10.1167/iovs.04-0118
Joussen AM, Heussen FM, Joeres S, Llacer H, Prinz B, Rohrschneider K, Maaijwee KJ, van Meurs J, Kirchhof B (2006) Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration. Am J Ophthalmol 142(1):17–30. doi:10.1016/j.ajo.2006.01.090
van Meurs JC, Van Den Biesen PR (2003) Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: short-term follow-up. Am J Ophthalmol 136(4):688–695
Treumer F, Bunse A, Klatt C, Roider J (2007) Autologous retinal pigment epithelium-choroid sheet transplantation in age-related macular degeneration: morphological and functional results. Br J Ophthalmol 91(3):349–353. doi:10.1136/bjo.2006.102152
Szurman P, Roters S, Grisanti S, Aisenbrey S, Schraermeyer U, Luke M, Bartz-Schmidt KU, Thumann G (2006) Ultrastructural changes after artificial retinal detachment with modified retinal adhesion. Invest Ophthalmol Vis Sci 47(11):4983–4989. doi:10.1167/iovs.06-0491
Christiansen AT, Tao SL, Smith M, Wnek GE, Prause JU, Young MJ, Klassen H, Kaplan HJ, la Cour M, Kiilgaard JF (2012) Subretinal implantation of electrospun, short nanowire, and smooth poly(epsilon-caprolactone) scaffolds to the subretinal space of porcine eyes. Stem Cells Int 2012:454295. doi:10.1155/2012/454295
Nazari H, Zhang L, Zhu D, Chader GJ, Falabella P, Stefanini F, Rowland T, Clegg DO, Kashani AH, Hinton DR, Humayun MS (2015) Stem cell based therapies for age-related macular degeneration: the promises and the challenges. Prog Retin Eye Res 48:1–39. doi:10.1016/j.preteyeres.2015.06.004
Tezel TH, Del Priore LV, Kaplan HJ (2004) Reengineering of aged Bruch’s membrane to enhance retinal pigment epithelium repopulation. Invest Ophthalmol Vis Sci 45(9):3337–3348. doi:10.1167/iovs.04-0193
Gullapalli VK, Sugino IK, Van Patten Y, Shah S, Zarbin MA (2005) Impaired RPE survival on aged submacular human Bruch’s membrane. Exp Eye Res 80(2):235–248. doi:10.1016/j.exer.2004.09.006
Phillips SJ, Sadda SR, Tso MO, Humayan MS, de Juan E Jr, Binder S (2003) Autologous transplantation of retinal pigment epithelium after mechanical debridement of Bruch’s membrane. Curr Eye Res 26(2):81–88
Hillenkamp J, Hussain AA, Jackson TL, Cunningham JR, Marshall J (2004) The influence of path length and matrix components on ageing characteristics of transport between the choroid and the outer retina. Invest Ophthalmol Vis Sci 45(5):1493–1498
Pauleikhoff D, Loffert D, Spital G, Radermacher M, Dohrmann J, Lommatzsch A, Bird AC (2002) Pigment epithelial detachment in the elderly. Clinical differentiation, natural course and pathogenetic implications. Graefes Arch Clin Exp Ophthalmol 240(7):533–538. doi:10.1007/s00417-002-0505-8
Ahir A, Guo L, Hussain AA, Marshall J (2002) Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch’s membrane. Invest Ophthalmol Vis Sci 43(2):458–465
Falabella P, Koss MJ, Stefanini FR, Pfister M, Chader GJ, Thomas BB, Thomas P, Clegg DO, Hinton DR, Humayun MS (2014) Safety outcome of subretinal human embryonic stem cell-derived pigment epithelium (hESC-RPE) transplantation in Yucatan mini-pigs with oral or intravenous immunosupression. Invest Ophthalmol Vis Sci 55(13):2674
Swindle MM, Makin A, Herron AJ, Clubb FJ Jr, Frazier KS (2012) Swine as models in biomedical research and toxicology testing. Vet Pathol 49(2):344–356. doi:10.1177/0300985811402846
This work is supported by the California Institute for Regenerative Medicine DR1-01444, TG2-01161, TG2-01151, CL1-00521 and FA1-00616 grants, NIH Core Grant EY03040, Research to Prevent Blindness, The Arnold and Mabel Beckman Foundation, The Beatrice Apple Revocable Living Trust, The Garland Initiative for Vision, The Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program, and the UCSB Institute for Collaborative Biotechnologies through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the Government, and no official endorsement should be inferred. Michael Koss received a research fellowship grant from the German Research Foundation (DFG), Bonn, Germany (DFG Ko4294/1-1). The authors thank Ernesto Baron and his team for excellent technical assistance with the histology. We also thank J. Cito Habicht, PhD, and Teisha R. Rowland, PhD, who provided writing and editing assistance.
The California Institute for Regenerative Medicine provided financial support in the form of grant funding (DR1-01444, TG2-01161, TG2-01151, CL1-00521, and FA1-00616). The U.S. National Institutes of Health provided financial support in the form of grant funding (NIH Core Grant EY03040). Research to Prevent Blindness, The Arnold and Mabel Beckman Foundation, The Beatrice Apple Revocable Living Trust, The Garland Initiative for Vision, The Foundation Fighting Blindness Wynn-Gund Translational Research Acceleration Program, and the UCSB Institute for Collaborative Biotechnologies provided financial support through grant W911NF-09-0001 from the U.S. Army Research Office. The content of the information does not necessarily reflect the position or the policy of the U.S. Government, and no official endorsement should be inferred. The German Research Foundation (DFG), Bonn, Germany provided financial support in the form of a research fellowship grant to Michael J. Koss (DFG Ko4294/1-1).
The sponsors had no role in the design or conduct of this research.
Conflict of interest
MSH, DRH, and DOC are co-founders of Regenerative Patch Technologies (RPT), LLC. All other authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.
About this article
Cite this article
Koss, M.J., Falabella, P., Stefanini, F.R. et al. Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs. Graefes Arch Clin Exp Ophthalmol 254, 1553–1565 (2016). https://doi.org/10.1007/s00417-016-3386-y
- Human embryonic stem cells
- Retinal pigment epithelium
- Macular degeneration
- Preclinical trial
- Animal model